Transport of Iodothyronines by Human L-Type Amino Acid Transporters

Chantal Zevenbergen, Marcel Meima, ECL de Souza, Robin Peeters, A Kinne, G Krause, Edward Visser, Theo Visser

Research output: Contribution to journalArticleAcademicpeer-review

45 Citations (Scopus)


Thyroid hormone (TH) transporters facilitate cellular TH influx and efflux, which is paramount for normal physiology. The L-type amino acid transporters LAT1 and LAT2 are known to facilitate TH transport. However, the role of LAT3, LAT4, and LAT5 is still unclear. Therefore, the aim of this study was to further characterize TH transport by LAT1 and LAT2 and to explore possible TH transport by LAT3, LAT4, and LAT5. FLAG-LAT1-5 constructs were transiently expressed in COS1 cells. LAT1 and LAT2 were cotransfected with the CD98 heavy chain. Cellular transport was measured using 10 nM I-125-labeled T-4, T-3, rT(3), 3,3'-T-2, and 10 mu M [I-125]3'-iodotyrosine (MIT) as substrates. Intracellular metabolism of these substrates was determined in cells cotransfected with either of the LATs with type 1 or type 3 deiodinase. LAT1 facilitated cellular uptake of all substrates and LAT2 showed a net uptake of T-3, 3,3'-T2, and MIT. Expression of LAT3 or LAT4 did not affect transport of T-4 and T-3 but resulted in the decreased cellular accumulation of 3,3'-T-2 and MIT. LAT5 did not facilitate the transport of any substrate. Cotransfection with LAT3 or LAT4 strongly diminished the cellular accumulation of 3,3'-T-2 and MIT by LAT1 and LAT2. These data were confirmed by metabolism studies. LAT1 and LAT2 show distinct preferences for the uptake of the different iodocompounds, whereas LAT3 and LAT4 specifically facilitate the 3,3'-T-2 and MIT efflux. Together our findings suggest that different sets of transporters with specific influx or efflux capacities may cooperate to regulate the cellular thyroid state.
Original languageUndefined/Unknown
Pages (from-to)4345-4355
Number of pages11
Issue number11
Publication statusPublished - 2015

Research programs

  • EMC MM-01-39-03

Cite this